Related Experiment Video
Updated: Jan 11, 2026

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.7K
An Interpretable Deep Learning Framework for Biomarker Discovery in Complex Disease Survival Outcomes
Shiyu Wan1, Xinlei Mi2, Fei Zou1,3
1Department of Biostatistics, University of North Carolina at Chapel Hill.
Biorxiv : the Preprint Server for Biology
|November 19, 2025
Summary
SurvDNN, a novel deep learning framework, accurately identifies biomarkers for complex disease survival. It enhances predictive accuracy and model robustness for precision medicine applications.
Area of Science:
- Biomedical data science
- Computational biology
- Genomics and bioinformatics
Background:
- Identifying biomarkers for complex disease survival is crucial for understanding disease mechanisms and advancing precision medicine.
- Time-to-event data presents challenges due to its complexity, including non-linear interactions and high dimensionality.
- Conventional survival data modeling approaches struggle with these complexities.
Purpose of the Study:
- To propose SurvDNN, a deep neural network framework tailored for survival outcome modeling.
- To enhance model robustness and mitigate overfitting in survival data analysis.
- To enable interpretable biomarker discovery through an extended Permutation-based Feature Importance Test (PermFIT).
Main Methods:
- Developed SurvDNN, a deep neural network framework for survival outcomes.
- Incorporated bootstrapping-based regularization to reduce overfitting.
- Implemented a stability-driven filtering algorithm for improved model robustness.
- Extended Permutation-based Feature Importance Test (PermFIT) for interpretable biomarker quantification.
Main Results:
- SurvDNN demonstrated superior performance compared to existing machine learning methods in simulations and real-world data.
- Achieved higher accuracy in both biomarker identification and predictive modeling.
- PermFIT provided robust quantification of individual biomarker contributions.
Conclusions:
- SurvDNN coupled with PermFIT offers a powerful, interpretable, and robust tool for biomarker-driven survival modeling.
- The framework holds significant potential for advancing precision medicine in complex diseases like cancer and cardiovascular disorders.
- An open-source R package for SurvDNN is available for public use.
Related Concept Videos
Cancer Survival Analysis
633
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
633
Kaplan-Meier Approach
541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388

